IIA
OBIO icon

IPG Investment Advisors’s Orchestra BioMed OBIO Stock Holding History

IPG Investment Advisors’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,250
Closed -$108K – 199
2024
Q2 		$108K Buy
+13,250
New +$76.8K 0.02% 165

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

IPG Investment Advisors's OBIO Position: Q3 2024 in Review

IPG Investment Advisors sold out of Orchestra BioMed (OBIO) in Q3 2024, closing a stake of 13,250 shares — an estimated $108K sold.

IPG Investment Advisors first reported a position in OBIO in Q2 2024 and held it in 1 quarter. The position peaked at $108K in Q2 2024. 48 funds tracked by Wall St. Rank hold OBIO as of Q3 2024.

  • IPG Investment Advisors reported no remaining Orchestra BioMed position as of Q3 2024 after selling out during the quarter.
  • IPG Investment Advisors sold 13,250 Orchestra BioMed shares in Q3 2024, an estimated $108K.
  • IPG Investment Advisors first reported a position in Orchestra BioMed in Q2 2024 and held it in 1 quarter.
  • IPG Investment Advisors's Orchestra BioMed position peaked at $108K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2024.

Based on IPG Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.